Skip to main content
profile image
Selected Works of Philip Mease, MD
Article
Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison
(2018)
  • Peter Nash, University of Queensland
  • Iain B. McInnes, University of Glasgow
  • Philip J. Mease, University of Washington
  • Howard Thom, University of Bristol
  • Matthias Hunger
  • Andreas Karabis
  • Kunal Gandhi, Novartis
  • Shephard Mpofu, Novartis
  • Steffen M. Jugl, Novartis
Link
Disciplines
Publication Date
March 31, 2018
DOI
10.1007/s40744-018-0106-6
Citation Information
Peter Nash, Iain B. McInnes, Philip J. Mease, Howard Thom, et al.. "Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison" (2018) p. 1 - 24
Available at: http://works.bepress.com/philip-mease/1/